Market Price

24.80 

0.05 0.2%

as of Jan 27 '23

52 Week Range:

14.80 25.15


Stock Analyzer Tutorials

S2O Stock Analyzer - General Info

General Info


type: video (mp4); length: 3:30

Demonstrates how to use Stock Analyzer, shows how to analyze a stock and explains in detail "General Info" section of the Stock Analyzer result page.

S2O Stock Analyzer - Financial Statements

Financial Statements


type: video (mp4); length: 5:10

Explains information presented in the Financial Statements section of the S2O Stock Analyzer: financial statements charts, absolute values and growth rates.

S2O Stock Analyzer - Growth Grade and Financial Ratios

Growth Grade and Financial Ratios


type: video (mp4); length: 5:09

Demonstrates how to use Growth Grade & Financial Ratios section; shows the difference between historical and year-over-year Growth Grade on the real life example.

S2O Stock Analyzer - Value Price

Value Price


type: video (mp4); length: 6:03

Demonstrates how to use Value Price (intrinsic value) and the Graham Number, MOS (margin of safety) and IRT - Investment Recovery Time; explains 3 different projection models used to compute value price - pessimistic, moderate and optimistic.

S2O Stock Analyzer - Price Charts

Price Charts


type: video (mp4); length: 8:34

Demonstrates basic rules of how to read a candlestick chart, long and short term moving averages, stochastic, MACD and relative strength (RS) charts. Explains how bull or bear market condition is computed.

General Info

AlzChem Group AG, together with its subsidiaries, develops, produces, and trades chemical products in Germany, European Union, rest of Europe, Asia, NAFTA region, and internationally. It operates through three segments: Specialty Chemicals, Basics & Intermediates, and Other & Holding. The company offers dietary supplements under the Creapure and Alipure brands; preparation of guanidinoacetic acid as a nutritional feed additives under the Creamino brand; creatine dietary supplements under the LIVADUR brand; products for pharmaceuticals under the Bioselect brand; curing agents, including accelerators for use in adhesives, powder coatings, printed circuit boards, and composites under the DYHARD name; and silicon nitride for ceramics, and electronics and solar applications under the SILZOT brand. It also provides fine and specialty chemicals, including products based on calcium carbide, calcium cyanamide, hydrogen cyanamide, dicyandiamide, guanidine, guanamines, and nitroguanidine, as well as aromatic and aliphatic nitriles; calcium cyanamide under the PERLKA name; germicide for use in pig pens under the ALZOGUR name; plant growth regulators under the Dormex and Sitofex name; and plant protection additives under the BREAK-THRU name. In addition, the company offers products for use in hot metal desulfurization and secondary metallurgy applications; and technical gases. Further, it provides chemical park operations and administrative services, as well as produces and distributes various infrastructure services. AlzChem Group AG was founded in 1908 and is based in Trostberg, Germany.

Financial Statements

The charts below show selected Annual and Quarterly Financial Data.

The purpose of these charts is to discover long and short term change dynamics. When numbers are growing year after year in the annual statements chart, the business become stronger and stronger and this is a good sign.

Quarterly Data Chart can be used to do a short term analysis. It makes sense to pay attention to the quarterly dynamics and do not wait for the next yearly statement. We should be alerted if we see that quarterly numbers are going down.

You can check "Annual Financial Statements" and "Quarterly Financial Statements" sections for exact numbers and growth rates.

Annual Statements

On a charts below the Line shows absolute values and the Bar chart shows Year-Over-Year Growth Rate for selected financial statement item. A consistent GROWTH is generally considered necessary to fund future growth from within a business.
NOTE: Growth Rate is not provided if either the latest period or the year-ago period contains a net loss. (source: WSJ Digest of Earnings)
TIP! move your mouse pointer over bar or a circle on any chart below to see details.

Financial Statements

Income Statement



 

Cash Flow Statement



 

Balance Sheet



 

Liquidity Ratios

Current Ratio


 

Current Ratio measures the ability to meet short term obligations. Generally accepted standard is 2 (current assets should be 2 times or 200% of current liabilities).

Quick Ratio


 

Measures immediate liquidity or the cash available to cover immediate liabilities. A safe margin would be at least 1 (100%).

Financial Leverage


 

Defined as total assets divided by total shareholders' equity. The higher the ratio, the more debt a company uses in its capital structure.

Profitability Ratios

ROA


 

Return on Assets (ROA) measures the income (profit) that is generated by the use of the assets of the business.

ROE


 

Return on Equity (ROE) is a measure of profitability that calculates how many dollars of profit a company generates with each dollar of shareholders equity. ROE is sometimes called "return on net worth."

ROIC


 

The Return on Invested Capital (ROIC) measure gives a sense of how well a company is using its money to generate returns. Some investors use this figure as a final evaluation to determine whether or not to invest in a company.

Annual Statements

Item Name Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Jun '18 Dec '18 Dec '19 Dec '20 Dec '21
Equity (BVPS) 11.59
11.53
14.63
11.95
11.84
5.54
6.13
7.84
growth rate -0.5% 26.9% -18.3% -0.9% -17.3% 10.7% 27.9%
Earnings BIT 297.03
498.00
570.00
656.00
826.00
31.99
45.07
32.08
28.17
31.31
36.84
growth rate 67.7% 14.5% 15.1% 25.9% -96.1% 40.9% -28.8% -12.2% 11.1% 17.7%
Avg.PE 17.39
19.31
15.44
23.56
34.41
7.64
13.18
8.63
growth rate 11.0% -20.0% 52.6% 46.1% -31.4% 72.5% -34.5%
ROA -23.77
-31.89
-41.37
-99.44
-56.80
14.55
7.63
5.48
5.65
7.54
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% -27.6% -28.2% 3.1% 33.5%
ROE -34.89
-81.96
-830.08
34.08
52.69
73.26
36.93
28.37
31.10
35.71
growth rate 0.0% 0.0% 100.0% 54.6% 39.0% -29.0% -23.2% 9.6% 14.8%
ROIC -34.90
-81.97
-830.11
31.78
52.69
32.04
21.97
16.91
16.73
20.34
growth rate 0.0% 0.0% 100.0% 65.8% -39.2% -17.2% -23.0% -1.1% 21.6%
Cur. Ratio 3.54
2.08
2.60
0.55
0.22
1.81
1.76
2.16
2.21
2.00
growth rate -41.2% 25.0% -78.9% -60.0% 722.7% -1.4% 22.7% 2.3% -9.5%
Quick Ratio 3.36
1.33
2.42
0.27
0.04
0.73
0.65
0.78
0.91
0.72
growth rate -60.4% 82.0% -88.8% -85.2% 1,725.0% -5.6% 20.0% 16.7% -20.9%
Leverage 1.59
7.05
1.43
1.45
1.59
5.03
4.68
5.73
5.30
4.31
growth rate 343.4% -79.7% 1.4% 9.7% 216.4% -3.5% 22.4% -7.5% -18.7%
Balance Sheet Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Jun '18 Dec '18 Dec '19 Dec '20 Dec '21
Acct.Receivable 414.00
406.00
401.00
428.00
446.00
46.00
59.84
41.84
39.77
38.85
49.43
growth rate -1.9% -1.2% 6.7% 4.2% -89.7% 30.1% -30.1% -4.9% -2.3% 27.3%
Acct.Payable 91.00
104.00
74.00
84.00
83.00
28.20
30.62
30.86
24.07
20.88
32.78
growth rate 14.3% -28.9% 13.5% -1.2% -66.0% 8.6% 0.8% -22.0% -13.3% 57.0%
Cur.Assets 1,631.00
2,020.00
1,726.00
963.00
1,193.00
137.52
154.60
142.55
130.60
132.46
152.58
growth rate 23.9% -14.6% -44.2% 23.9% -88.5% 12.4% -7.8% -8.4% 1.4% 15.2%
Total Assets 2,694.00
3,030.00
2,748.00
1,915.00
2,106.00
280.18
304.46
313.55
342.58
354.30
377.67
growth rate 12.5% -9.3% -30.3% 10.0% -86.7% 8.7% 3.0% 9.3% 3.4% 6.6%
Cash 1,022.00
628.00
1,205.00
405.00
495.00
12.80
9.84
12.86
9.06
17.12
8.29
growth rate -38.6% 91.9% -66.4% 22.2% -97.4% -23.1% 30.6% -29.5% 88.9% -51.6%
Inventory 56.00
53.00
61.00
62.00
136.00
71.38
75.58
78.86
74.61
67.40
86.68
growth rate -5.4% 15.1% 1.6% 119.4% -47.5% 5.9% 4.3% -5.4% -9.7% 28.6%
Cur.Liabilities 460.00
972.00
665.00
421.00
569.00
76.01
85.41
81.16
60.49
59.87
76.13
growth rate 111.3% -31.6% -36.7% 35.2% -86.6% 12.4% -5.0% -25.5% -1.0% 27.2%
Liabilities 1,176.00
1,321.00
827.00
600.00
785.00
222.29
230.42
245.16
281.23
285.64
288.10
growth rate 12.3% -37.4% -27.5% 30.8% -71.7% 3.7% 6.4% 14.7% 1.6% 0.9%
LT Debt 235.00
235.00
19.20
16.40
32.58
50.75
48.04
37.55
growth rate 0.0% -46.5% -14.6% 98.6% 55.8% -5.3% -21.8%
Equity 1,258.31
1,416.08
55.67
72.62
66.97
59.76
66.90
87.63
growth rate 12.5% -55.5% 30.4% -7.8% -10.8% 11.9% 31.0%
Common Shares 118.00
115.00
116.00
112.00
108.00
10.00
101.76
101.76
101.76
101.76
101.76
growth rate -2.5% 0.9% -3.5% -3.6% -90.7% 917.6% 0.0% 0.0% 0.0% 0.0%
Cash Flow Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Jun '18 Dec '18 Dec '19 Dec '20 Dec '21
Capital Expenditures 34.00
21.00
25.00
19.00
33.00
24.88
31.92
40.13
41.38
28.83
28.54
growth rate -38.2% 19.1% -24.0% 73.7% -24.6% 28.3% 25.7% 3.1% -30.3% -1.0%
Cash Dividends 77.64
93.88
17.78
11.19
11.19
9.16
7.63
7.82
growth rate 20.9% -34.0% -37.0% 0.0% -18.2% -16.7% 2.5%
Cash From OA 572.00
592.00
159.00
658.00
920.00
30.66
30.87
34.66
43.63
48.71
43.02
growth rate 3.5% -73.1% 313.8% 39.8% -96.7% 0.7% 12.3% 25.9% 11.6% -11.7%
FCF per Share 1.16
3.66
0.84
5.41
6.40
0.17
1.03
1.08
growth rate 215.5% -77.1% 544.1% 18.3% -59.6% 505.9% 4.9%
FCF 533.00
565.00
129.00
614.00
862.00
6.00
-1.05
-5.00
2.00
20.00
43.00
growth rate 6.0% -77.2% 376.0% 40.4% -99.3% -100.0% 0.0% 100.0% 900.0% 115.0%
Income Statement Dec '12 Dec '13 Dec '14 Dec '15 Dec '16 Dec '17 Jun '18 Dec '18 Dec '19 Dec '20 Dec '21
Sales 1,728.00
1,786.00
1,958.00
2,045.00
2,418.00
360.99
398.47
383.07
385.03
386.07
429.41
growth rate 3.4% 9.6% 4.4% 18.2% -85.1% 10.4% -3.9% 0.5% 0.3% 11.2%
Op.Income 303.00
498.00
570.00
656.00
826.00
31.99
45.07
32.08
28.17
31.31
36.84
growth rate 64.4% 14.5% 15.1% 25.9% -96.1% 40.9% -28.8% -12.2% 11.1% 17.7%
IBT 297.05
356.05
29.34
44.71
31.92
25.49
27.20
36.51
growth rate 19.9% -46.4% 52.4% -28.6% -20.1% 6.7% 34.3%
Net Income 303.00
453.00
594.00
552.00
696.00
20.39
32.01
22.64
17.98
19.69
27.59
growth rate 49.5% 31.1% -7.1% 26.1% -97.1% 57.0% -29.3% -20.6% 9.6% 40.1%
EPS -0.03
-0.04
-0.04
-0.14
-0.13
2.00
2.30
1.77
1.94
2.72
growth rate 0.0% 0.0% 0.0% 0.0% 100.0% 7.2% -23.0% 9.6% 40.2%
Gross Profit 1,077.00
1,174.00
1,305.00
1,405.00
1,641.00
213.52
238.74
222.94
227.48
240.39
258.30
growth rate 9.0% 11.2% 7.7% 16.8% -87.0% 11.8% -6.6% 2.0% 5.7% 7.5%
R&D 381.57
335.83
growth rate -12.0%

Quarterly Statements

Item Name Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Earnings BIT 7.63
5.16
10.26
9.58
5.82
growth rate -32.4% 98.8% -6.6% -39.2%
Balance Sheet Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Acct.Receivable 77.73
49.43
71.32
80.82
85.69
growth rate -36.4% 44.3% 13.3% 6.0%
Acct.Payable 32.78
44.78
growth rate 16.9%
Cur.Assets 159.19
152.58
187.38
217.91
226.67
growth rate -4.2% 22.8% 16.3% 4.0%
Total Assets 381.27
377.67
403.97
427.89
436.68
growth rate -0.9% 7.0% 5.9% 2.1%
Cash 6.91
8.29
8.44
10.20
9.51
growth rate 20.0% 1.8% 20.9% -6.8%
Inventory 74.56
86.68
107.62
126.90
131.48
growth rate 16.3% 24.2% 17.9% 3.6%
Cur.Liabilities 82.64
76.13
104.72
141.17
148.10
growth rate -7.9% 37.6% 34.8% 4.9%
Liabilities 299.96
288.10
290.02
295.80
297.44
growth rate -4.0% 0.7% 2.0% 0.6%
LT Debt 37.55
32.53
growth rate -6.9%
Equity 81.31
87.63
113.95
130.07
139.24
growth rate 7.8% 30.0% 14.2% 7.1%
Common Shares 81.31
101.76
113.95
101.76
139.24
growth rate 25.2% 12.0% -10.7% 36.8%
Cash Flow Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Capital Expenditures 28.54
28.54
7.36
7.72
growth rate 0.0% -74.2% 4.9%
Cash Dividends 7.82
7.82
10.14
10.14
growth rate 0.0% 29.6% 0.0%
Cash From OA -0.78
18.09
-5.58
-11.59
3.07
growth rate 100.0% -100.0% 0.0% 100.0%
FCF -29.31
-10.45
-12.94
-19.31
growth rate 0.0% 0.0% 0.0%
Income Statement Sep '21 Dec '21 Mar '22 Jun '22 Sep '22
Sales 98.06
109.53
131.15
142.41
145.15
growth rate 11.7% 19.7% 8.6% 1.9%
Op.Income 7.63
5.16
10.26
9.58
5.82
growth rate -32.4% 98.8% -6.6% -39.2%
IBT 7.34
5.21
11.34
13.26
7.54
growth rate -29.0% 117.8% 16.9% -43.2%
Net Income 4.69
5.85
7.70
9.59
5.93
growth rate 24.6% 31.7% 24.5% -38.1%
EPS
growth rate
Gross Profit 62.26
51.76
69.76
80.09
67.88
growth rate -16.9% 34.8% 14.8% -15.2%
R&D
growth rate

Growth Grade & Financial Ratios

All financial ratios below are calculated based on latest annual statements available and present the most up to date snapshot of a company finances.

Growth Grade

Historical Growth Grade:

E (33.25)

YOY Growth Grade:

D (35.27)

Click on buttons above for detailed yearly growth rates.

Market Ratios

Profitability Ratios

Liquidity Ratios

Efficiency Ratios

Value Price

PE and EPS

Historical Current Forward
PE 8.91 12.82 19.58
EPS / Growth 1.94 10.7%

Value Price & Investment Recovery Time

Read more about Stock2Own value price in Stock Market: Fundamental Analysis.

Equity Growth Rate: 1.0%

Estimates Pessimistic Moderate Optimistic My Numbers
Rate of Return 15.0%
MOS Price % 50 %
Future EPS Growth 1.0% 5.9% 5.9%
Future PE 2.00 13.40 13.40
Future EPS 2.14 3.42 3.42
Value Price
MOS %
1.06
-95.7%
11.31
-54.4%
11.31
-54.4%
MOS Price 0.53 5.66 5.66
IRT 12.01 9.41 9.41

Graham Number:

NOTE: The Graham Number applies only to certain types of stocks in combination with a number of other criteria.

Read more about Graham Number in Stock Market: Fundamental Analysis.

Price Chart

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.

Risk / Reward Ratios

The functionality you are trying to reach is available to registered users only.

Login to your account or Register Now if you are not registered yet. Registration is FREE and will take only a minute.